New Key Statistics Module, Z-Score and F-Score
NAS:GTHX Key Ratios
| Market Cap $ M | 377.22 |
| Enterprise Value $ M | 364.45 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 134.91 |
| Price/Book | 15.31 |
| Price/Sales | 6.40 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 58.00 |
| EPS (TTM) $ | -0.86 |
| Beneish M-Score | -2.81 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 17.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -10.71 |
| EV-to-EBITDA | -10.87 |
| PEG | -- |
| Shares Outstanding M | 52.76 |
| Net Margin (%) | -76.93 |
| Operating Margin % | -65.09 |
| Pre-tax Margin (%) | -73.83 |
| Quick Ratio | 2.12 |
| Current Ratio | 2.48 |
| ROA % (ttm) | -37.11 |
| ROE % (ttm) | -118.89 |
| ROIC % (ttm) | -225.16 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.11 |
GTHX Number of Guru Trades
GTHX Volume of Guru Trades
Gurus Latest Trades with NAS:GTHX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:GTHX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
G1 Therapeutics Inc Insider Transactions
No Available Data
News about NAS:GTHX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers